Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
24.49
+1.57 (6.85%)
Jul 6, 2026, 4:00 PM EDT - Market closed
Faeth Therapeutics Employees
Faeth Therapeutics had 29 employees as of December 31, 2025. The number of employees increased by 14 or 93.33% compared to the previous year.
Employees
29
Change (1Y)
14
Growth (1Y)
93.33%
Revenue / Employee
n/a
Profits / Employee
-$6,360,586
Market Cap
631.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | 14 | 93.33% | 29 | 0 |
| Dec 31, 2024 | 15 | -13 | -46.43% | 14 | 1 |
| Dec 31, 2023 | 28 | 0 | - | 27 | 1 |
| Dec 31, 2022 | 28 | -28 | -50.00% | 28 | 0 |
| Dec 31, 2021 | 56 | 24 | 75.00% | 56 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| ProKidney | 231 |
| Neurogene | 131 |
| Editas Medicine | 87 |
| Assembly Biosciences | 73 |
| SpyGlass Pharma | 68 |
| AgomAb Therapeutics NV | 62 |
| Altimmune | 57 |
FTH News
- 3 days ago - Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 11 days ago - Faeth Therapeutics initiated with an Outperform at Baird - TheFly
- 15 days ago - Faeth Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 18 days ago - Faeth Therapeutics files automatic mixed securities shelf - TheFly
- 22 days ago - Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer - Business Wire
- 4 weeks ago - Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - Business Wire
- 2 months ago - Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer - Business Wire